A general technique linking micro-scale affinity capture with matrix-assisted laser desorption/ ionization (MALDI) mass spectrometric detection has been developed for the rapid, sensitive and accurate determination of antigens present in biological fluids. Strategies for the qualitative and quantitative determination of single and/or multiple antigens are presented.
INffiODUC1ION
We have recently developed a method for the rapid and sensitive determination of antigenic species present in biological fluids. The technique, depicted in Fig. 1 , has been termed mass spectrometric immunoassay (MSIA) /1/. Viewed in its simplest form, MSIA is the combination of nano-scale immunoaffinity chromatography th matrix-assisted laser desorption/ionization (MALDI) mass spectrometly. Each of the separate techniques contributes its own complementaiy abilities to the total assay -the selective concentration of species through inimunoaflinity isolation, and the molecular weight-specific detection of mass spectrometry -the combination of which is an extremely powerful method for the sensitive qualitative identification of affinants towards the immobilized aflinity ligands. However, while antigen identification by virtue of molecular weight is fairly obvious, antigen quantitation (necessary to complete the assay) is not.
Considering that the criteria for successful quantitative MALDI analysis -the need to introduce an internal reference species (IRS) into the mass analysis in order to compensate for signal variations due to different laser iimdiances and sample preparations /2/ -are further complicated by the sub-microliter volumes associated with the affinity isolation step, novel methods of IRS introduction are necessitated. These methods should be, within reason, fairly independent of both the volume of the analytical sample, and the volume of the affinity reagent. The most obvious approach is introduction in a manner analogous to that by which the analyte is retained, i.e., the internal reference species is introduced into solution to be retrieved by the affinity reagent. In this way, precise quantities of IRS can be delivered into the relatively large volumes of analytical sample (100's of microliters). Also, as long as the affInity reagent is not saturated by either the analyte or IRS, the approach becomes independent of the volume of affinity reagent used. Retrieval of the IRS can be accomplished using a number of methods including the use of a single antibody to capture both the antigen and a modified variant of the antigen (used as an IRS). Rinse flg. 1 General scheme of MSJA. Antigens are isolated by incubation of the analytical solution for 15 minutes with antibodies (covalently immobilized to solid supports), and retained through a series of washes (to remove unwanted compounds). Antigen is then eluted on to a mass spectrometer probe tip and detected at precise and characteristic mass values using MALDI mass spectrometiy. The entire assay requires approximately 20 minutes to perform.
EXPERIMENTAL
The experimental protocols employed during these studies were with few exceptions identical to those reported in reference 1. Briefly, immunoaflinity reagent was prepared by covalent attachment of polyclonal antibodies (with affInity towards selected toxins) to beaded agarose/protein A. The reagent was prepared for use by placement of 2 jtL of sluthed beads in a chamber constructed in a micropipettor tip (the beads effectively retained in the tip). Reagent was then incubated with whole blood samples containing quantitative internal reference species (at constant concentration) and either purified toxin (at variable concentrations -for calibration) or whole venom from rattlesnakes (as analytical samples) by repetitively flowing the blood sampies through the pipettor tips for 15 minutes. Reagent was washed in a similar manner by flowing wash buffers through the pipettor tips. Retained antigen was eluted by driving 3 jtL of MALDI matrix over the beaded reagent (still retained in the pipettor tip), the matrix/analyte mixture applied directly to a mass spectrometer probe tip. Samples were 416 /SPIE Vol. 2680
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Elute with Matrix m/z allowed to air dry before insertion into the time-of-flight instrument. MALDI analyses proceeded following normal acquisition protocols.
3.1 Mass speclitnuehic immunoassay 3. RESULTS Fig. 2 shows the results of a qualitative MSJA applied to the isolation of the toxin, myotoxin a (MTh, MW = 4,822 Da), from human whole blood containing 0.05 mg/mL Cv. viridis venom. The top trace is a normal MALDI spectrum of human whole blood and exhibits characteristics of matrix overload by too much protein (the poor signal-to-noise ratio and resolution). It might be noted that much higher quality spectra were obtained from the venom-laced blood sample upon dilution, however, as is typical of the analysis of whole blood, little other than signals due to hemoglobin (A and B chains) were observed and the myotoxin a was undetectable. Normal MALDI spectrum ofhuman whole blood laced to contain 0.05 mg/mL whole venom of the prairie rattlesnake. (Center aixi bottom) MSIA spectra (using a reagent of anti-myotoxin a) of the same blood sample and one containing 0.0002 mg/mL whole venom.
The middle trace shows a spectrum resulting from a MSJA (in which immobilized polyclonal anti-myotoxin a was used as an affinity reagent) of the same blood sample. Ion signals are observed corresponding to the presence of a species with a molecular weight of 4,820 Da, within 2 Da of the molecular weight of the myotoxin a. Virtually no other signals are observed in this spectrum, in which the myotoxin a concentration of parent sample was later determined to be 630 nanomolar (see below). However, greater contributions from (presumably) non-specifically bound proteins were observed during MSJA of samples containing much lower concentrations of the rattlesnake venom. This is shown in the spectrum obtained from a blood sample containing 0.0002 mg/mL whole venom (bottom trace). Despite the appearance of multiple non-analyte signals, the presence of myotoxin a is indicated unambiguously by the signal at m/z = 4,820 Da (control spectra of samples containing no myotoxin a show no signals in the region of the toxin signal). The myotoxin a concentration of this sample was determined to be -250 picomolar; the 200 jtL sample containing ' 50 femtomol of toxin.
With the specificity derived through the direct detection of antigens at precise mass values, many of the restrictions of conventional assays (ELISA, RTA) are overcome. Most importantly, detection of antigens becomes unambiguous, thereby eliminating false positives. But when the ability of time-of-flight mass spectrometry to simultaneously detect several mass-resolved species is considered, a number of more complex assays are viewed possible. The least of these are assays designed to simultaneously screen for the presence of multiple antigens. Assays of this nature are not much harder to construct or perform than those screening for a single antigen the main difference being the affinity reagent is prepared with antibodies toward multiple antigens rather than just one. Fig. 3 shows the results of such a multiple-antigen assay. Again, human whole blood was used as an analytical fluid, yet this time laced with venom from the Mojave rattlesnake (Cs. scutulatw). An MSIA reagent containing immobilized antibodies toward both myotoxin a and the basic subunit to Mojave toxin was used. Observed in the MSIA spectrum are signals due to; myotoxin a (mlz = 4,820 Da), Mojave toxin basic subunit (mlz = 14,200 Da), Mojave toxin acidic subunit (heterogeneous at m/z 9,000 Da) and hemoglobin subunits (m/z = 15,126 and 15,867 Da, for A and B respectively). The origin ofthe two toxin signals is self explanatory (retained by the immobilized antibodies), however, of interest are the signals from the hemoglobin and the Mojave toxin acidic subunits. The hemoglobin signals are due to non-specific binding of the proteins to the beaded agarose (as blank studies have shown), and are of variable relative strengths dependent on how rigorously the affinity reagent is washed after incubation. The Mojave toxin acidic subunit, on the other hand, is retained "piggyback" to the basic subunit, i.e., through true affinity interactions, and less susceptible to dissociation due to wash conditions. Since all species appear at unique mass to charge values, the non-targeted proteins, which in total account for the majority ofthe ion signals observed in the mass spectrum, do not interfere with the unambiguous determination of the two toxins 3.2 Quanhitalive MSIA As previously stated, quantitative determination of proteins using MALDI requires the use of internal references species, kept at constant concentration in each calibrant and analytical sample, for inter-sample spectra normalization. While quantitatively accurate introduction of standards into large volumes of analytical solution is fairly easy, introduction into small volumes, where volumetric differences in delivery are substantially more significant, is considerably more difficult. Such is the case with MSIA, where analytes are retained on volumes of reagent which are relatively small (sub-microliter) and sometimes hard to control. Hence methods of introducing internal references into analytical samples are needed which are independent of the volume of the affinity reagent and in the which errors in delivery do not limit the accuracy of the analysis.
The simplest method for "fixing" the quantity of internal reference during the MSJA process is that of retaining the species on the affmity reagent along th the analyte. This is accomplished during MSIA using antibodies directed toward a single antigen by introducing a chemically modified version of the antigen (the modifications resulting in a resolvable mass-shifted antigen which still exhibits an affinity towards the immobilized antibodies) into the analysis to serve as the internal reference. Fig. 4 shows the a series of MSIA spectra used to calibrate and determine the concentration of myotoxin a present in a blood sample containing 0.002 mg/niL prairie rattlesnake whole venom. The six traces in the overlay were obtained from blood samples containing purified myotoxin a at concentrations between 10 100 nM A version of the myotoxin a in which the lysines had been converted to homoarginine (H-MTA, MW = 5,242 Da) was introduced into each sample at a constant concentration (30 nM) and used as an internal reference species (all spectra were normalized to the H-MITA signal). A myotoxin a concentration of 25 nM was determined for the analytical sample (inset). 5 shows an alternate approach in which a series of modified variants of the antigen were introduced into the analytical sample to serve as an internal calibration "bargraph" for antigen quantification. Shown in the trace are four versions ofthe myotoxin a, each shifted 126 Da in molecular weight from the previous (the internal reference species were versions of myotoxin a in which the tyrosine and/or histidine residues were iodinated). The distribution (y-axis) of the modified variant is staggered, with the magnitude of each providing an intensity register indicative of a particular concentration of myotoxin a. The intensity of the myotoxin a signal is observed to register between those of the first and fourth modified versions indicating a toxin concentration of between 20 and 30 nM (for blood laced to contain 0.002 mg/mL venom).
CJONCLUSK)N
Mass spectrometric immunoassays capable of the rapid, sensitive and accurate detection of antigens have been developed. The assays utilize micro-scale immunoaflinity isolation to selectively concentrate antigens from solution prior to mass-specific detection using MALDI mass spectrometry. Because ofthe resolution and accuracy intrinsic to mass spectrometry a number of analytical variations are possible, the least of these being assays capable of the simultaneous detection of multiple antigens. The abilities of mass spectrometry further allow the incorporation of mass-resolved internal reference species, in the form of chemically modified variants of antigens (retained in most cases by the antibodies directed towards the target antigens) into the analyses for the purpose of antigen quantitation. 
